Press releasePRNewswire
Zimmer Biomet Holdings
ZBH · NYSE
$96.00+$1.01 (+1.06%)TodayMarket closed ·
Prev close $94.99
Latest news
- NewsRishabh Mishra
Michael Burry Warns Anthropic’s Valuation Could Buy 78 Profitable S&P 500 Companies: ‘Fun Game in Times Like These’
- Press releasePRNewswire
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
- Press releasePRNewswire
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
- Press releasePRNewswire
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
- News
Zimmer Biomet Holdings Q2 Adj. EPS $2.07 Beats $2.01 Estimate, Sales $2.177B Beat $2.134B Estimate
- Press releasePRNewswire
Zimmer Biomet Announces Second Quarter 2026 Financial Results
- Press releasePRNewswire
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
- Press releasePRNewswire
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
- News
Pacira BioSciences Divests Iovera To Zimmer Biomet For Up To $140M
- Press releasePRNewswire
Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
- Press releasePRNewswire
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026
- NewsTanya Rawat
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'
- Press releasePRNewswire
Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End
- Press releasePRNewswire
Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference
- NewsAvi Kapoor
These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results
- NewsPiero Cingari
Stock Market Today: S&P 500 Drops Amid Tech Sell-Off, Oil Climbs To $100 On Hormuz Drama
- NewsVandana Singh
Tariffs Benefit, CFO Exit: What's Going On With Zimmer Biomet Stock On Tuesday?
- News
Transcript: Zimmer Biomet Holdings Q1 2026 Earnings Conference Call
- Press releasePRNewswire
Zimmer Biomet Announces First Quarter 2026 Financial Results
- Press releasePRNewswire
Zimmer Biomet Announces Chief Financial Officer Transition
- Press releasePRNewswire
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results
- Press releasePRNewswire
Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
- Press releaseGlobe Newswire
Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm
- Press releasePRNewswire
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting
- Press releasePRNewswire
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026
- Press releasePRNewswire
ZBH Investor Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
- Press releasePRNewswire
Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results
- Press releasePRNewswire
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
- Press releasePRNewswire
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
- Press releaseGlobe Newswire
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
- Press releasePRNewswire
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results
- Press releasePRNewswire
Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference
- NewsPiero Cingari
Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday?
- Press releasePRNewswire
Zimmer Biomet Announces Third Quarter 2025 Financial Results
- News
FDA Grants Breakthrough Device Designation For Zimmer Biomet's First-To-World Iodine-Treated Total Hip Replacement System
- Press releasePRNewswire
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
- Press releasePRNewswire
Zimmer Biomet Completes Acquisition of Monogram Technologies
- Press releasePRNewswire
Zimmer Biomet Completes Acquisition of Monogram Technologies
- Press releasePRNewswire
Zimmer Biomet Announces Second Quarter 2025 Financial Results
- News
P/E Ratio Insights for Zimmer Biomet Holdings
- Press releasePRNewswire
Zimmer Biomet Announces First Quarter 2025 Financial Results
- News
Price Over Earnings Overview: Zimmer Biomet Holdings
- Press releasePRNewswire
Zimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.